老年高血压合并冠心病患者心血管代谢性共病流行特征及预后研究

Clinical characteristics and prognosis of cardiometabolic disease in elderly patients with hypertension and coronary artery heart disease

  • 摘要:
    背景 老年高血压(hypertension,HT)合并冠心病(coronary atherosclerotic heart disease,CAD)人群占比重,心血管代谢性共病(cardiometabolic disease,CMD)逐渐成为我国老年人最常见的多病共存模式,老年高血压合并冠心病(HT-CAD)患者CMD的流行病学特征及预后鲜有研究。目的 探讨老年高血压合并冠心病(HT-CAD)患者心血管代谢性共病(CMD)的流行趋势及预后。方法 研究共纳入2008 — 2018年就诊于解放军总医院心内科的年龄≥65岁高血压合并冠心病患者,所有患者均随访至2023年9月。根据是否存在代谢性共病将患者分为HT-CAD组、HT-CAD合并脑卒中组(HT-CAD-STR)、HTCAD合并糖尿病组(HT-CAD-DM)和HT-CAD合并脑卒中及糖尿病组(HT-CAD-STR-DM),使用Cox回归模型计算各组全因死亡风险比(HR)和95%置信区间(CI)。结果 共纳入患者8 258例,研究人群中HT-CAD、HT-CAD-STR、HT-CAD-DM和HT-CAD-STR-DM四组患者分别为3 454例(41.83%)、884例(10.70%)、3 054例(36.98%)及866例(10.49%)。2008 — 2018年间,HT-CAD 患者占比呈降低趋势(45.52% vs 38.88%)(趋势 P<0.01),而 HT-CAD-STR-DM 患者占比呈增加趋势(8.38% vs 12.53%)(趋势性检验P<0.01)。与其他三组相比,HT-CAD-STR-DM组患者心率更快、体质指数更高且高密度脂蛋白更低,合并心力衰竭、慢性肾脏病、急性心肌梗死比例更高。经过中位6.38年的随访后,共有6 843例患者完成随访,共随访到1 281 例死亡事件。四组患者的事件例数及发生率分别为:HT-CAD 组:435/2 885,23.55/千人年;HT-CAD-STR 组:125/743,26.36/千人年;HT-CAD-DM组:530/2 499,33.24/千人年;HT-CAD-STR-DM组:191/716,41.82/千人年。Cox回归分析结果显示:与 HT-CAD 组相比,HT-CAD-DM 组全因死亡风险增加 38%(HR:1.38;95% CI:1.21 ~ 1.57),HT-CADSTR-DM组全因死亡风险增加73%(HR:1.73;95% CI:1.45 ~ 2.05),而HT-CAD-STR组全因死亡风险未见显著增加。分层分析显示:合并脑卒中不会导致老年HT-CAD患者全因死亡风险增加,但会导致老年HT-CAD-DM患者全因死亡风险增加26%;合并糖尿病使老年 HT-CAD 患者全因死亡风险增加 39%,使老年 HT-CAD-STR 患者全因死亡风险增加 71%。结论 老年HT-CAD患者心血管代谢性共病患病率高且逐年增加。合并糖尿病的老年HT-CAD患者全因死亡风险高。糖尿病和脑卒中对老年HT-CAD患者全因死亡风险存在协同效应。

     

    Abstract:
    Background The proportion of elderly patients with hypertension and coronary artery disease (HT-CAD) is high. Cardiometabolic disease (CMD) has gradually become the most common coexistence mode of multiple diseases among elderly people in China. The epidemic trend and prognosis of CMD in elderly patients with HT-CAD is rarely studied. Objective To explore the clinical characteristics and prognosis of cardiometabolic disease in elderly patients with HT-CAD.Methods From 2008 to 2018, elderly inpatients (aged ≥ 65 years) with HT-CAD from Department of Cardiology, Chinese PLA General Hospital were included in the study. All patients were followed up until September 2023, and divided into four groups, including HT-CAD group, HT-CAD combined with stroke (HT-CAD-STR)group, HT-CAD combined with diabetes (HT-CAD-DM) group、 HT-CAD with stroke and diabetes (HT-CAD-STR-DM) group. Cox regression model was used to calculate the hazard ratio (HR) and 95%  confidence interval (CI) of all-cause mortality in each group.Results A total of 8 258 patients were included in this study, including 3 454 patients (41.83%) in the HT-CAD group, 884 patients (10.70%) in the HT-CAD-STR group, 3,054 patients (36.98%) in the HT-CAD-DM group and 866 patients (10.49%) in the HT-CAD-STR-DM group. From 2008 to 2018, the proportion of HT-CAD patients decreased (45.52% vs 38.88%), and the proportion of HT-CAD-STR-DM patients increased (8.38% vs 12.53%) (trend test P < 0.01). Compared with the other three groups, patients in the HT-CAD-STR-DM group had a faster heart rate, a higher body mass index and a lower level of high-density lipoprotein, and a higher proportion of heart failure (HF), chronic kidney disease (CKD) and acute myocardial infarction (AMI). After a median follow-up of 6.38 years, a total of 6 843 patients completed the follow-up, 1 281 cases of death were identified. The number of events and their incidence rates for the four groups of patients were as follows: HTCAD group: 435/2885, 23.55 per 1 000 person-years; HT-CAD-STR group: 125/743, 26.36 per 1 000 person-years; HT-CAD-DM group: 530/2499, 33.24 per 1 000 person-years; HT-CAD-STR-DM group: 191/716, 41.82 per 1 000 person-years. Multivariate Cox regression model showed that the HR (95% CI) of all-cause mortality were 1.38 (1.21-1.57) for the HT-CAD-DM patients and 1.73 (1.45-2.05) for the HT-CAD-STR-DM patients compared to those with HT-CAD, while the risk of all-cause mortality did not significantly increase in the HT-CAD-STR patients. Stratified analysis by diabetes showed that stroke was not associated with increased risk of all-cause death in elderly patients with HT-CAD, but increased the risk by 26% in elderly HT-CAD-DM patients. Moreover, stratified analysis by stroke showed that diabetes increased the risk of all-cause mortality by 39% in elderly HT-CAD, but increased the risk by 71% in elderly HT-CAD-STR patients.Conclusion The prevalence of cardiometabolic disease is high among elderly HT-CAD patients and it keeps increasing year by year. Elderly HT-CAD patients with diabetes have a higher risk of all-cause mortality. Diabetes and stroke show synergistic effects on the risk of all-cause death in elderly HT-CAD patients.

     

/

返回文章
返回